These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
522 related items for PubMed ID: 26373628
21. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Mov Disord; 2015 Apr 15; 30(5):646-54. PubMed ID: 25487613 [Abstract] [Full Text] [Related]
22. [Cardiovascular alpha-, beta 1- and beta 2-adrenoceptor functions in neurogenic orthostatic hypotension]. Tamura N, Shimazu K, Yamamoto T, Maeda A, Hamaguchi K. Rinsho Shinkeigaku; 1995 Oct 15; 35(10):1120-4. PubMed ID: 8821496 [Abstract] [Full Text] [Related]
23. Managed care approach to the treatment of neurogenic orthostatic hypotension. Isaacson SH. Am J Manag Care; 2015 Oct 15; 21(13 Suppl):s258-68. PubMed ID: 26790110 [Abstract] [Full Text] [Related]
24. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). Hauser RA, Hewitt LA, Isaacson S. J Parkinsons Dis; 2014 Oct 15; 4(1):57-65. PubMed ID: 24326693 [Abstract] [Full Text] [Related]
25. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials. Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K. Ann Pharmacother; 2018 Dec 15; 52(12):1182-1194. PubMed ID: 29972032 [Abstract] [Full Text] [Related]
26. Neurogenic hyperadrenergic orthostatic hypotension: a newly recognized variant of orthostatic hypotension in older adults with elevated norepinephrine (noradrenaline). Mar PL, Shibao CA, Garland EM, Black BK, Biaggioni I, Diedrich A, Paranjape SY, Robertson D, Raj SR. Clin Sci (Lond); 2015 Jul 15; 129(2):107-16. PubMed ID: 25706983 [Abstract] [Full Text] [Related]
27. Hyperinsulinemia and Insulin Resistance in Dopamine β-Hydroxylase Deficiency. Arnold AC, Garland EM, Celedonio JE, Raj SR, Abumrad NN, Biaggioni I, Robertson D, Luther JM, Shibao CA. J Clin Endocrinol Metab; 2017 Jan 01; 102(1):10-14. PubMed ID: 27778639 [Abstract] [Full Text] [Related]
28. Orthostatic hypotension for the cardiologist. Mar PL, Raj SR. Curr Opin Cardiol; 2018 Jan 01; 33(1):66-72. PubMed ID: 28984649 [Abstract] [Full Text] [Related]
29. Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension. Imrich R, Eldadah BA, Bentho O, Pechnik S, Sharabi Y, Holmes C, Grossman E, Goldstein DS. Parkinsonism Relat Disord; 2009 Feb 01; 15(2):122-7. PubMed ID: 18514012 [Abstract] [Full Text] [Related]
30. Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. François C, Hauser RA, Aballéa S, Dorey J, Kharitonova E, Hewitt LA. J Med Econ; 2016 Feb 01; 19(5):515-25. PubMed ID: 26710315 [Abstract] [Full Text] [Related]
31. Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension. François C, Rowse GJ, Hewitt LA, Vo P, Hauser RA. BMC Neurol; 2016 Aug 18; 16(1):143. PubMed ID: 27538531 [Abstract] [Full Text] [Related]
32. Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease. McCullough PA. Cardiol Ther; 2019 Jun 18; 8(1):145-150. PubMed ID: 30627953 [Abstract] [Full Text] [Related]
33. Droxidopa for Symptomatic Neurogenic Hypotension. Ferguson-Myrthil N. Cardiol Rev; 2017 Jun 18; 25(5):241-246. PubMed ID: 28604565 [Abstract] [Full Text] [Related]
34. Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient. Gentric A, Fouilhoux A, Caroff M, Mottier D, Jouquan J. J Am Geriatr Soc; 1993 May 18; 41(5):550-1. PubMed ID: 8486891 [Abstract] [Full Text] [Related]
35. Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension. Isonaka R, Rosenberg AZ, Sullivan P, Corrales A, Holmes C, Sharabi Y, Goldstein DS. Hypertension; 2019 Apr 18; 73(4):910-918. PubMed ID: 30798661 [Abstract] [Full Text] [Related]
36. Pharmacologic treatment of orthostatic hypotension. Park JW, Okamoto LE, Shibao CA, Biaggioni I. Auton Neurosci; 2020 Dec 18; 229():102721. PubMed ID: 32979782 [Abstract] [Full Text] [Related]
37. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H. J Neurol; 2017 Aug 18; 264(8):1567-1582. PubMed ID: 28050656 [Abstract] [Full Text] [Related]
38. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency. Man in 't Veld AJ, Boomsma F, van den Meiracker AH, Schalekamp MA. Lancet; 1987 Nov 21; 2(8569):1172-5. PubMed ID: 2890807 [Abstract] [Full Text] [Related]
39. Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. Sharabi Y, Imrich R, Holmes C, Pechnik S, Goldstein DS. Mov Disord; 2008 Sep 15; 23(12):1725-32. PubMed ID: 18661549 [Abstract] [Full Text] [Related]
40. New developments in the management of neurogenic orthostatic hypotension. Biaggioni I. Curr Cardiol Rep; 2014 Nov 15; 16(11):542. PubMed ID: 25303896 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]